Clinical Trial Update: Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of MLN1202 in patients with multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• MLN1202

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED